SCHEMBL9298056

SCHEMBL9298056

CC(=O)CC(C)CCN1CN(CC(C)=O)c2c1[nH]c(=O)[nH]c2=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7318006 0.89 HTT (0.36) —
SCHEMBL11078950 0.75 — —
SCHEMBL31074878 0.66 KDM4E (0.31) —
SCHEMBL9843267 0.66 TYMP (0.36) —
SCHEMBL9388000 0.62 TYMP (0.32) —
SCHEMBL5174201 0.59 HTT (0.36) —
SCHEMBL31074881 0.59 — —
SCHEMBL7403408 0.59 TYMP (0.34) —
SCHEMBL7617986 0.59 TYMP (0.36) —
SCHEMBL11315769 0.57 ALDH1A1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350753-A Treatment of bacterial infectious diseases and septic shock HOECHST AKTIENGESELLSCHAFT (DE) 1994-09-27 — — US claimed
Send feedback